Basal Cell Carcinoma (BCC) of the Skin
Also known as: Skin Basal Cell Carcinoma / Basal Cell Carcinoma of the Skin
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01169 | Arsenic trioxide | 0 | Withdrawn | 1 |
| DB04456 | Arsenous acid | 0 | Withdrawn | 1 |
| DB01167 | Itraconazole | 0 | Completed | 1 |
| DB01167 | Itraconazole | 0 | Withdrawn | 1 |
| DB08828 | Vismodegib | 0 | Completed | 1 |
| DB00992 | Methyl aminolevulinate | 1 | Completed | 1 |
| DB01169 | Arsenic trioxide | 1 / 2 | Completed | 1 |
| DB04456 | Arsenous acid | 1 / 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
| DB08828 | Vismodegib | 1 / 2 | Completed | 1 |
| DB00855 | Aminolevulinic acid | 2 | Active Not Recruiting | 1 |
| DB17833 | Dimericine | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB14869 | Remetinostat | 2 | Completed | 1 |
| DB13896 | Talimogene laherparepvec | 2 | Active Not Recruiting | 1 |
| DB01042 | Melphalan | Not Available | Withdrawn | 1 |